Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-02

AUTHORS

Yukihiro Miyazaki, Yuichiro Nawa, Masao Miyagawa, Sumiko Kohashi, Koichi Nakase, Masaki Yasukawa, Masamichi Hara

ABSTRACT

The treatment of patients with diffuse large B cell lymphoma (DLBCL) would be greatly facilitated with a rapid method for determining prognosis that can be performed more easily and earlier than cytological or specific pathological examinations. It has been suggested that newly diagnosed patients with DLBCL who have low maximum standard uptake value (SUV(max)) on (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) are more likely to be successfully treated and remain in remission compared with patients with high SUV(max), but this concept has been poorly studied. We retrospectively analyzed 50 patients with de novo DLBCL to evaluate the relationship between the SUV(max) and disease progression. For patients with low SUV(max) (n = 10) and high SUV(max) (n = 40) (P = 0.255), respectively, the 3-year overall survival rates were 90 and 72 %, and the progression-free survival (PFS) rates were 90 and 39 % (P = 0.012). By multivariate analysis, the revised International Prognostics Index (R-IPI) and SUV(max) at diagnosis were shown to predict longer PFS. The 3-year PFS for patients with low SUV(max) classified into the good prognosis group by R-IPI was 100 vs. 62 % for those with high SUV(max) (P = 0.161), and patients with low SUV(max) classified into the poor prognosis group by R-IPI was 80 vs. 18 % for those with high SUV(max) (P = 0.050). We conclude that the SUV(max) on FDG-PET for newly diagnosed patients with DLBCL is an important predictor of disease progression, especially for patients with poor prognosis by R-IPI. More... »

PAGES

239-244

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3

DOI

http://dx.doi.org/10.1007/s00277-012-1602-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016010275

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23079891


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Murine-Derived", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorine Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma, Large B-Cell, Diffuse", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Selection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron-Emission Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisolone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rituximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vincristine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Ehime Prefectural Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414413.7", 
          "name": [
            "Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Shitsukawa, 791-0295, Toon, Ehime, Japan", 
            "Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyazaki", 
        "givenName": "Yukihiro", 
        "id": "sg:person.01002012476.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002012476.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ehime Prefectural Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414413.7", 
          "name": [
            "Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nawa", 
        "givenName": "Yuichiro", 
        "id": "sg:person.01235232263.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235232263.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ehime Prefectural Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414413.7", 
          "name": [
            "Division of Radiology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyagawa", 
        "givenName": "Masao", 
        "id": "sg:person.01076114534.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076114534.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ehime Prefectural Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414413.7", 
          "name": [
            "Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kohashi", 
        "givenName": "Sumiko", 
        "id": "sg:person.01070340147.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070340147.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ehime Prefectural Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414413.7", 
          "name": [
            "Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakase", 
        "givenName": "Koichi", 
        "id": "sg:person.01174736411.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174736411.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ehime University", 
          "id": "https://www.grid.ac/institutes/grid.255464.4", 
          "name": [
            "Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Shitsukawa, 791-0295, Toon, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yasukawa", 
        "givenName": "Masaki", 
        "id": "sg:person.0730073225.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730073225.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ehime Prefectural Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414413.7", 
          "name": [
            "Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hara", 
        "givenName": "Masamichi", 
        "id": "sg:person.0702377030.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702377030.82"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1093/annonc/mdn392", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002958217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-011-0822-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004034909", 
          "https://doi.org/10.1007/s12185-011-0822-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-011-0822-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004034909", 
          "https://doi.org/10.1007/s12185-011-0822-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0609.2010.01467.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006085010"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199309303291402", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013554742"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctrv.2007.02.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020576240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.08.2305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020848737"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(11)70235-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021792870"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2003-06-2095", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022035062"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10428190903440953", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024334269"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2003-05-1545", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026049587"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood.v99.3.815", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027088442"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2010-03-276246", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031111650"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2006-08-038257", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036676724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.2403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045509899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(08)70002-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047262140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199512073332305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048188294"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.28.1618", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049306116"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2007-06-097238", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050417265"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2008-06-155820", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050529744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.16.3025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074684756"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-02", 
    "datePublishedReg": "2013-02-01", 
    "description": "The treatment of patients with diffuse large B cell lymphoma (DLBCL) would be greatly facilitated with a rapid method for determining prognosis that can be performed more easily and earlier than cytological or specific pathological examinations. It has been suggested that newly diagnosed patients with DLBCL who have low maximum standard uptake value (SUV(max)) on (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) are more likely to be successfully treated and remain in remission compared with patients with high SUV(max), but this concept has been poorly studied. We retrospectively analyzed 50 patients with de novo DLBCL to evaluate the relationship between the SUV(max) and disease progression. For patients with low SUV(max) (n\u2009=\u200910) and high SUV(max) (n\u2009=\u200940) (P\u2009=\u20090.255), respectively, the 3-year overall survival rates were 90 and 72\u00a0%, and the progression-free survival (PFS) rates were 90 and 39\u00a0% (P\u2009=\u20090.012). By multivariate analysis, the revised International Prognostics Index (R-IPI) and SUV(max) at diagnosis were shown to predict longer PFS. The 3-year PFS for patients with low SUV(max) classified into the good prognosis group by R-IPI was 100 vs. 62\u00a0% for those with high SUV(max) (P\u2009=\u20090.161), and patients with low SUV(max) classified into the poor prognosis group by R-IPI was 80 vs. 18\u00a0% for those with high SUV(max) (P\u2009=\u20090.050). We conclude that the SUV(max) on FDG-PET for newly diagnosed patients with DLBCL is an important predictor of disease progression, especially for patients with poor prognosis by R-IPI.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00277-012-1602-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1018247", 
        "issn": [
          "1269-3286", 
          "1279-8509"
        ], 
        "name": "Annals of Hematology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "92"
      }
    ], 
    "name": "Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma", 
    "pagination": "239-244", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4c4919d5ae29fa07f5de7f2edb167c549eea3316563238abc4e9c3cc55d5f008"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23079891"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9107334"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-012-1602-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016010275"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-012-1602-3", 
      "https://app.dimensions.ai/details/publication/pub.1016010275"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T14:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000487.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00277-012-1602-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-012-1602-3'


 

This table displays all metadata directly associated to this object as RDF triples.

293 TRIPLES      21 PREDICATES      78 URIs      50 LITERALS      38 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-012-1602-3 schema:about N014a3c0981fe4d0b83932f0ce50b8069
2 N03cd84b7119a4f28bbf31351d7974a62
3 N1cf82cf028804c748c79206e7a894cfc
4 N37adfe9b91ed4b27a202c65e66ac23c4
5 N39596e1e0e3e4a42ace0eba061973ec9
6 N5a69a65c8e484b898cf79df8db588ada
7 N6aea7bb431a1453b8c5e14a6bca5f9e6
8 N86d62ff07b2046e7aafadf7562ed6cde
9 N88f2cc0a23fe4e97968a7c4bfc0ee8db
10 N8dae82672ce1476c88aba1065aeebd24
11 N8e1ae36089384dcc8cc0ee0a3023f0ba
12 N9b609ac67fe94d5eb1b4bb59311a90db
13 N9c5b807197fc43338d2eccd07c19e64b
14 Naa4ae020ba39411aaa922ddd8df835f9
15 Nb1163169c89f431583963693c9197b0a
16 Nb52f03db8b66435595b51964a5d70421
17 Nb9f4e1bfc68a4781906d49268631fa64
18 Nc2b507e20000459badfb5fe647576e09
19 Nc4ff8fa16c0e462eb71440c34cf49167
20 Nc54aec4b3686432c9803e7c8c6fc757c
21 Nc844b5e8d1f245c3bf9ce2650b8d483c
22 Ncd1971e04ab945f08690c1392efa94cb
23 Nde130535185e4452adf3e5d217c433bc
24 Ndeebfda27cae4ac2b491d23d217f33a2
25 Ne0958d81606541fb8d3fe86bcd7f80dd
26 Ne9f76f31d52140ad8a806649ee99e6eb
27 Neaf80ea070c74f51bf8a587e541a3c52
28 Nef177a7fa18b41f98df921d7a650eab0
29 Nf8bdf0da70294a18bd676a056493e547
30 anzsrc-for:11
31 anzsrc-for:1103
32 schema:author N08d079026de64a4ca2005ecc09776df1
33 schema:citation sg:pub.10.1007/s12185-011-0822-y
34 https://doi.org/10.1016/j.ctrv.2007.02.002
35 https://doi.org/10.1016/s1470-2045(08)70002-0
36 https://doi.org/10.1016/s1470-2045(11)70235-2
37 https://doi.org/10.1056/nejm199309303291402
38 https://doi.org/10.1056/nejm199512073332305
39 https://doi.org/10.1093/annonc/mdn392
40 https://doi.org/10.1111/j.1600-0609.2010.01467.x
41 https://doi.org/10.1182/blood-2003-05-1545
42 https://doi.org/10.1182/blood-2003-06-2095
43 https://doi.org/10.1182/blood-2006-08-038257
44 https://doi.org/10.1182/blood-2007-06-097238
45 https://doi.org/10.1182/blood-2008-06-155820
46 https://doi.org/10.1182/blood-2010-03-276246
47 https://doi.org/10.1182/blood.v99.3.815
48 https://doi.org/10.1200/jco.2000.18.16.3025
49 https://doi.org/10.1200/jco.2006.08.2305
50 https://doi.org/10.1200/jco.2006.09.2403
51 https://doi.org/10.1200/jco.2010.28.1618
52 https://doi.org/10.3109/10428190903440953
53 schema:datePublished 2013-02
54 schema:datePublishedReg 2013-02-01
55 schema:description The treatment of patients with diffuse large B cell lymphoma (DLBCL) would be greatly facilitated with a rapid method for determining prognosis that can be performed more easily and earlier than cytological or specific pathological examinations. It has been suggested that newly diagnosed patients with DLBCL who have low maximum standard uptake value (SUV(max)) on (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) are more likely to be successfully treated and remain in remission compared with patients with high SUV(max), but this concept has been poorly studied. We retrospectively analyzed 50 patients with de novo DLBCL to evaluate the relationship between the SUV(max) and disease progression. For patients with low SUV(max) (n = 10) and high SUV(max) (n = 40) (P = 0.255), respectively, the 3-year overall survival rates were 90 and 72 %, and the progression-free survival (PFS) rates were 90 and 39 % (P = 0.012). By multivariate analysis, the revised International Prognostics Index (R-IPI) and SUV(max) at diagnosis were shown to predict longer PFS. The 3-year PFS for patients with low SUV(max) classified into the good prognosis group by R-IPI was 100 vs. 62 % for those with high SUV(max) (P = 0.161), and patients with low SUV(max) classified into the poor prognosis group by R-IPI was 80 vs. 18 % for those with high SUV(max) (P = 0.050). We conclude that the SUV(max) on FDG-PET for newly diagnosed patients with DLBCL is an important predictor of disease progression, especially for patients with poor prognosis by R-IPI.
56 schema:genre research_article
57 schema:inLanguage en
58 schema:isAccessibleForFree true
59 schema:isPartOf N3f1c35765c4341d68336cdc9e873f7d4
60 Nb03b7b0af3b84218864765171f592c39
61 sg:journal.1018247
62 schema:name Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma
63 schema:pagination 239-244
64 schema:productId N1bf23e7434c04567911840613fa4d5e2
65 N1cc4c6f364044e8bb089026c7a2dc49f
66 N68853d6aaf9b473eb29822ee302dbc9c
67 N69eb8afd5e264f94a7af1d435d73a4d4
68 N94028a3020d242f3b2b6f47453a4e37a
69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016010275
70 https://doi.org/10.1007/s00277-012-1602-3
71 schema:sdDatePublished 2019-04-10T14:54
72 schema:sdLicense https://scigraph.springernature.com/explorer/license/
73 schema:sdPublisher N61ff914411484234b69217df3a7d417c
74 schema:url http://link.springer.com/10.1007/s00277-012-1602-3
75 sgo:license sg:explorer/license/
76 sgo:sdDataset articles
77 rdf:type schema:ScholarlyArticle
78 N014a3c0981fe4d0b83932f0ce50b8069 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Retrospective Studies
80 rdf:type schema:DefinedTerm
81 N03cd84b7119a4f28bbf31351d7974a62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Cyclophosphamide
83 rdf:type schema:DefinedTerm
84 N08d079026de64a4ca2005ecc09776df1 rdf:first sg:person.01002012476.64
85 rdf:rest N7d3f508b651a4b65923c8caea69ced7e
86 N194a2f94f7f6400fa24ea1ceb94f07f6 rdf:first sg:person.01174736411.20
87 rdf:rest Ne73a512a1ef24a1e8f8795e3535fef58
88 N1bf23e7434c04567911840613fa4d5e2 schema:name readcube_id
89 schema:value 4c4919d5ae29fa07f5de7f2edb167c549eea3316563238abc4e9c3cc55d5f008
90 rdf:type schema:PropertyValue
91 N1cc4c6f364044e8bb089026c7a2dc49f schema:name pubmed_id
92 schema:value 23079891
93 rdf:type schema:PropertyValue
94 N1cf82cf028804c748c79206e7a894cfc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Antineoplastic Combined Chemotherapy Protocols
96 rdf:type schema:DefinedTerm
97 N37adfe9b91ed4b27a202c65e66ac23c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Disease-Free Survival
99 rdf:type schema:DefinedTerm
100 N39596e1e0e3e4a42ace0eba061973ec9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Lymphoma, Large B-Cell, Diffuse
102 rdf:type schema:DefinedTerm
103 N3f1c35765c4341d68336cdc9e873f7d4 schema:issueNumber 2
104 rdf:type schema:PublicationIssue
105 N5a69a65c8e484b898cf79df8db588ada schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Treatment Outcome
107 rdf:type schema:DefinedTerm
108 N61ff914411484234b69217df3a7d417c schema:name Springer Nature - SN SciGraph project
109 rdf:type schema:Organization
110 N68853d6aaf9b473eb29822ee302dbc9c schema:name dimensions_id
111 schema:value pub.1016010275
112 rdf:type schema:PropertyValue
113 N69eb8afd5e264f94a7af1d435d73a4d4 schema:name nlm_unique_id
114 schema:value 9107334
115 rdf:type schema:PropertyValue
116 N6aea7bb431a1453b8c5e14a6bca5f9e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Aged, 80 and over
118 rdf:type schema:DefinedTerm
119 N74e812828a034d45818bda89627e5f36 rdf:first sg:person.0702377030.82
120 rdf:rest rdf:nil
121 N75433a0de379488a85fc0e85fcadfc30 rdf:first sg:person.01076114534.40
122 rdf:rest N808ce56baf6c4451b29694b241c407bc
123 N7d3f508b651a4b65923c8caea69ced7e rdf:first sg:person.01235232263.62
124 rdf:rest N75433a0de379488a85fc0e85fcadfc30
125 N808ce56baf6c4451b29694b241c407bc rdf:first sg:person.01070340147.42
126 rdf:rest N194a2f94f7f6400fa24ea1ceb94f07f6
127 N86d62ff07b2046e7aafadf7562ed6cde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Kaplan-Meier Estimate
129 rdf:type schema:DefinedTerm
130 N88f2cc0a23fe4e97968a7c4bfc0ee8db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Proportional Hazards Models
132 rdf:type schema:DefinedTerm
133 N8dae82672ce1476c88aba1065aeebd24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Humans
135 rdf:type schema:DefinedTerm
136 N8e1ae36089384dcc8cc0ee0a3023f0ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Patient Selection
138 rdf:type schema:DefinedTerm
139 N94028a3020d242f3b2b6f47453a4e37a schema:name doi
140 schema:value 10.1007/s00277-012-1602-3
141 rdf:type schema:PropertyValue
142 N9b609ac67fe94d5eb1b4bb59311a90db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Prednisolone
144 rdf:type schema:DefinedTerm
145 N9c5b807197fc43338d2eccd07c19e64b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Female
147 rdf:type schema:DefinedTerm
148 Naa4ae020ba39411aaa922ddd8df835f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Radiopharmaceuticals
150 rdf:type schema:DefinedTerm
151 Nb03b7b0af3b84218864765171f592c39 schema:volumeNumber 92
152 rdf:type schema:PublicationVolume
153 Nb1163169c89f431583963693c9197b0a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Doxorubicin
155 rdf:type schema:DefinedTerm
156 Nb52f03db8b66435595b51964a5d70421 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Age Factors
158 rdf:type schema:DefinedTerm
159 Nb9f4e1bfc68a4781906d49268631fa64 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Middle Aged
161 rdf:type schema:DefinedTerm
162 Nc2b507e20000459badfb5fe647576e09 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Rituximab
164 rdf:type schema:DefinedTerm
165 Nc4ff8fa16c0e462eb71440c34cf49167 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Aged
167 rdf:type schema:DefinedTerm
168 Nc54aec4b3686432c9803e7c8c6fc757c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Adult
170 rdf:type schema:DefinedTerm
171 Nc844b5e8d1f245c3bf9ce2650b8d483c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Combined Modality Therapy
173 rdf:type schema:DefinedTerm
174 Ncd1971e04ab945f08690c1392efa94cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Vincristine
176 rdf:type schema:DefinedTerm
177 Nde130535185e4452adf3e5d217c433bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Fluorodeoxyglucose F18
179 rdf:type schema:DefinedTerm
180 Ndeebfda27cae4ac2b491d23d217f33a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Positron-Emission Tomography
182 rdf:type schema:DefinedTerm
183 Ne0958d81606541fb8d3fe86bcd7f80dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Prognosis
185 rdf:type schema:DefinedTerm
186 Ne73a512a1ef24a1e8f8795e3535fef58 rdf:first sg:person.0730073225.12
187 rdf:rest N74e812828a034d45818bda89627e5f36
188 Ne9f76f31d52140ad8a806649ee99e6eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Male
190 rdf:type schema:DefinedTerm
191 Neaf80ea070c74f51bf8a587e541a3c52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Hematopoietic Stem Cell Transplantation
193 rdf:type schema:DefinedTerm
194 Nef177a7fa18b41f98df921d7a650eab0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Antibodies, Monoclonal, Murine-Derived
196 rdf:type schema:DefinedTerm
197 Nf8bdf0da70294a18bd676a056493e547 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Fluorine Radioisotopes
199 rdf:type schema:DefinedTerm
200 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
201 schema:name Medical and Health Sciences
202 rdf:type schema:DefinedTerm
203 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
204 schema:name Clinical Sciences
205 rdf:type schema:DefinedTerm
206 sg:journal.1018247 schema:issn 1269-3286
207 1279-8509
208 schema:name Annals of Hematology
209 rdf:type schema:Periodical
210 sg:person.01002012476.64 schema:affiliation https://www.grid.ac/institutes/grid.414413.7
211 schema:familyName Miyazaki
212 schema:givenName Yukihiro
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002012476.64
214 rdf:type schema:Person
215 sg:person.01070340147.42 schema:affiliation https://www.grid.ac/institutes/grid.414413.7
216 schema:familyName Kohashi
217 schema:givenName Sumiko
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070340147.42
219 rdf:type schema:Person
220 sg:person.01076114534.40 schema:affiliation https://www.grid.ac/institutes/grid.414413.7
221 schema:familyName Miyagawa
222 schema:givenName Masao
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076114534.40
224 rdf:type schema:Person
225 sg:person.01174736411.20 schema:affiliation https://www.grid.ac/institutes/grid.414413.7
226 schema:familyName Nakase
227 schema:givenName Koichi
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174736411.20
229 rdf:type schema:Person
230 sg:person.01235232263.62 schema:affiliation https://www.grid.ac/institutes/grid.414413.7
231 schema:familyName Nawa
232 schema:givenName Yuichiro
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235232263.62
234 rdf:type schema:Person
235 sg:person.0702377030.82 schema:affiliation https://www.grid.ac/institutes/grid.414413.7
236 schema:familyName Hara
237 schema:givenName Masamichi
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702377030.82
239 rdf:type schema:Person
240 sg:person.0730073225.12 schema:affiliation https://www.grid.ac/institutes/grid.255464.4
241 schema:familyName Yasukawa
242 schema:givenName Masaki
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730073225.12
244 rdf:type schema:Person
245 sg:pub.10.1007/s12185-011-0822-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1004034909
246 https://doi.org/10.1007/s12185-011-0822-y
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1016/j.ctrv.2007.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020576240
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1016/s1470-2045(08)70002-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047262140
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/s1470-2045(11)70235-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021792870
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1056/nejm199309303291402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013554742
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1056/nejm199512073332305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048188294
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1093/annonc/mdn392 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002958217
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1111/j.1600-0609.2010.01467.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1006085010
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1182/blood-2003-05-1545 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026049587
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1182/blood-2003-06-2095 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022035062
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1182/blood-2006-08-038257 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036676724
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1182/blood-2007-06-097238 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050417265
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1182/blood-2008-06-155820 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050529744
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1182/blood-2010-03-276246 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031111650
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1182/blood.v99.3.815 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027088442
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1200/jco.2000.18.16.3025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074684756
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1200/jco.2006.08.2305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020848737
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1200/jco.2006.09.2403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045509899
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1200/jco.2010.28.1618 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049306116
283 rdf:type schema:CreativeWork
284 https://doi.org/10.3109/10428190903440953 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024334269
285 rdf:type schema:CreativeWork
286 https://www.grid.ac/institutes/grid.255464.4 schema:alternateName Ehime University
287 schema:name Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Shitsukawa, 791-0295, Toon, Ehime, Japan
288 rdf:type schema:Organization
289 https://www.grid.ac/institutes/grid.414413.7 schema:alternateName Ehime Prefectural Central Hospital
290 schema:name Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Shitsukawa, 791-0295, Toon, Ehime, Japan
291 Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan
292 Division of Radiology, Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan
293 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...